Sign up here to get the latest press releases and financial reports from I-Tech AB directly to your inbox.
Your subscription is now saved and you will recive an email to verify your email address and activate the subscription.
Sorry, there was something wrong with your request.
We could not save your subscriptions please go back and try again.
Developers of Selektope®
I-Tech AB is a public held bio-technology company based in Mölndal, Sweden that owns all IP and regulatory rights to the antifouling agent Selektope® (generic name, medetomidine). I-Tech also controls the largest and most efficient source of medetomidine production.